Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: TFX

Teleflex Incorporated

Healthcare | Medical - Instruments & Supplies
$135.62 -0.94 (-0.69%) as of 2026-07-14 17:15 UTC
Market Cap$6.1B
EPS (TTM)$-20.25

Teleflex Incorporated (NYSE: TFX) is a $6.1B medical - instruments & supplies company trading at $135.62 (−0.7% today) — yielding 0.99%. Figures from SEC EDGAR and market feeds; updated 2026-07-14 17:15 UTC.

52-Week Range
Low $118.89High $138.56

What Teleflex Incorporated does

Teleflex is a global medical technology company that designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical settings. The company operates manufacturing facilities in the Czech Republic, Malaysia, Mexico and the United States, and sells its products worldwide through direct sales forces and distributors.

Summarized from Teleflex Incorporated’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$135.62
Change (1D)-0.94 (-0.69%)
Market cap$6.1B
52-week range$118.89 – $138.56
Valuation
EPS (TTM)$-20.25
Dividend yield0.99%
Price/book1.94×
Debt/equity0.85
Returns
52-week return+14.1%
Revenue, margins & earnings
FY2021 Net income: $485MFY2021 Taxes & interest: $143MFY2021 Operating expenses: $922MFY2021 Cost of revenue: $1.26B$2.81BFY2021FY2022 Net income: $363MFY2022 Taxes & interest: $137MFY2022 Operating expenses: $1.03BFY2022 Cost of revenue: $1.26B$2.79BFY2022FY2023 Revenue: $1.71B — margin split not shown (non-operating gains)$1.71BFY2023FY2024 Net income: $70MFY2024 Taxes & interest: $34MFY2024 Operating expenses: $934MFY2024 Cost of revenue: $662M$1.70BFY2024FY2025: net loss $906M on revenue $1.99B$1.99BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-09
  • 2026-06-09RANDLE STUART AF-4,054$526.4K
  • 2026-06-09RANDLE STUART AA995—
  • 2026-06-09RANDLE STUART AA4,663—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • BlackRock, Inc.5,023,075$600.81M-5.9%
  • VANGUARD GROUP INC4,675,013$570.54M-2.5%
  • JANUS HENDERSON GROUP PLC4,291,311$513.28M+1.1%
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Teleflex Incorporated do?

Teleflex is a global medical technology company that designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical settings.

What is TFX's valuation?

TFX trades at $135.62, as of 2026-07-14. It carries a 0.99% dividend yield.

When did TFX last file with the SEC?

Teleflex Incorporated's most recent SEC filing on record is a 8-K filed 2026-06-15. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 17:15 UTC. This page is also available as JSON at /api/data?ticker=TFX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for TFX and 3,500+ tickers.

Create a free account — keep TFX
For your agent
GET /api/data?ticker=TFX

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt